Transcription of Pre -Exposure Prophylaxis (PrEP): A primer for primary ...
{{id}} {{{paragraph}}}
Pre -Exposure Prophylaxis (PrEP): A primer for primary care providers Rev Daily emtricitabine/tenofovir (Truvada ) is safe and effective for reducing the risk of HIV acquisition in sexually active men and women and injection drug users. This primer will serve as a brief how to guide for providers interested in providing PrEP to their patients. 1) Identify patients who may benefit from PrEP The CDC guidance recommends that PrEP be offered to patients with ongoing, very high risk for acquiring HIV infection.
Pre -Exposure Prophylaxis (PrEP): A primer for primary care providers Rev 5.26.14 Daily emtricitabine/tenofovir (Truvada®) is safe and effective for reducing the risk of HIV acquisition in sexually active men and women and injection drug users.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Your, Exposure Control Plan, Exposure, MANAGING EXPOSURE TO TICKS ON YOUR, Managing Exposure toTicks on Your, Connecticut, Protect Your Family from Lead, CHROMIC OXIDE HAZARD SUMMARY WORKPLACE, Pesticides - Harmful Effects and Emergency, Minutes of reading time dramatically, Reducing Law Enforcement Liability - Louis, Reducing Law Enforcement Liability, Lightning Safety When Working Outdoors